Viewing Study NCT06561620


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2025-12-26 @ 3:03 AM
Study NCT ID: NCT06561620
Status: RECRUITING
Last Update Posted: 2024-08-22
First Post: 2024-08-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients
Sponsor:
Organization: